Search for: "Johnson v. French Market*" Results 41 - 60 of 63
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jun 2011, 12:46 pm by Bexis
Smith, Kline & French Laboratories, 447 So.2d 1301, 1305 (Ala. 1984).AlaskaShanks v. [read post]
21 Apr 2011, 1:36 pm by Bexis
April 24, 2007), a Stephens-Johnson case where the plaintiff took cephalexin, a generic form of Keflex, but nevertheless tried to sue the manufacturer of branded Keflex. [read post]
3 Mar 2011, 11:53 am by Eric
History * Antone Johnson on the dot-com hangover of 2000-2002 [read post]
25 Jan 2011, 7:24 am by Mandelman
Oh, look who’s here… Elizabeth Warren, I’m so pleased you were able to join us… let’s see where I’ve got you sitting… “Um, she can sit next to me…” Oh, Simon Johnson, of course… sorry, but I have you over here. [read post]
22 Nov 2010, 2:16 am by Kelly
(Ron Coleman’s Likelihood of Confusion) ONEL – Pieter Veeze’s 2010 Markenforum speech (Class 46) France Cour d’appel Paris: French law implementing London Protocol procedural so to be enforced immediately with retroactive effect: Unilever v. [read post]
1 Feb 2010, 3:04 am by Omar Ha-Redeye
Eugene Volokh discusses religious exemptions of a different type, from mandatory autopsies for executed killers in Johnson v. [read post]
27 Feb 2009, 7:00 am
(BLOG@IP::JUR) Changes to EPO fee structure, 1 April 2009 (BLOG@IP::JUR) (Patent Baristas) Changes of patent culture (BLOG@IP::JUR) MARQUES 3rd annual review of community design case law (Managing Intellectual Property) PDO amendment – Chabichou du Poitou (Class 46)   France French trade marks database opens publicly on 3 April 2009 (Class 46) Union pour un Mouvement Populaire to compensate MGMT for use of song ‘Kids’ at party rallies without seeking… [read post]
23 Jan 2009, 1:00 am
(Managing Intellectual Property) (Law360) (Out-Law) ECJ rules German music distributor cannot sell two Bob Dylan compilation albums because Sony owns rights to songs in question: Sony Music Entertainment (Germany) GmbH v Falcon Neue Medien Vertrieb GmbH (IPKat) (Law360) ECJ: Date set for Advocate General’s opinion in L'Oréal SA, Lancôme parfums et beauté & Cie SNC, Laboratoire Garnier & Cie v Bellure NV, Malaika… [read post]
2 Oct 2008, 7:43 pm
Strine notes that Unocal’s board met for eight or nine hours to consider Pickens’ offer — a response to Smith v. [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
13 Jun 2008, 3:40 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited v Hutchinson 3G UK Limited: (Out-Law), (Catch Us If You Can!!!) [read post]
11 May 2008, 4:14 am
  After a series of challenges, the United States Supreme Court approved the condemnation in Kelo v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]